Skip to main content

Table 2 Comparison of SD-OCT retinal and choroidal thickness subfield measurements in the SCD and control groups

From: Retinal and choroidal thickness in pediatric patients with sickle cell disease: a cross-sectional cohort study

  SCD Control p value
Mean µm ± standard deviation (median) Mean µm ± standard deviation (median)
Retinal thickness
 Central 256.39 ± 20.84 (256.00) 254.58 ± 18.89 (255.00) 0.748
 Superior parafovea 344.65 ± 21.13 (344.50) 340.06 ± 18.80 (337.00) 0.378
 Nasal parafovea 345.58 ± 17.21 (343.00) 334.00 ± 22.24 (330.00) 0.026*
 Inferior parafovea 343.07 ± 14.80 (342.00) 332.28 ± 18.26 (331.50) 0.011*
 Temporal parafovea 330.83 ± 16.02 (331.00) 322.14 ± 15.89 (320.00) 0.036*
 Superior perifovea 317.73 ± 13.24 (316.00) 311.18 ± 21.20 (305.00) 0.285
 Nasal perifovea 326.05 ± 15.06 (325.00) 319.75 ± 19.14 (318.50) 0.193
 Inferior perifovea 309.41 ± 17.15 (307.00) 300.96 ± 17.18 (299.00) 0.075
 Temporal perifovea 293.24 ± 11.09 (292.00) 291.60 ± 23.13 (286.00) 0.733
Choroidal thickness
 Subfovea 240.78 ± 21.27 (238.00) 275.87 ± 41.14 (262.50)  < 0.001*
 Temporal parafovea 231.08 ± 21.01 (230.00) 266.16 ± 43.43 (255.00)  < 0.001*
 Nasal parafovea 224.52 ± 17.97 (224.00) 251.44 ± 40.92 (236.00)  < 0.001*
 Temporal perifovea 220.15 ± 30.47 (212.00) 247.28 ± 47.18 (228.00)  < 0.001*
 Nasal perifovea 202.36 ± 17.53 (200.00) 220.69 ± 39.94 (214.50)  < 0.001*
  1. *p < 0.05 is significant